NOTE 8: Income Taxes

 

The Company’s financial statements include a total state tax expense of $2 on a loss before income taxes of approximately $15,754 for the years ended September 30, 2025. A reconciliation of the difference between the (expense)/benefit for income taxes and income taxes at the statutory U.S. federal income tax rate is as follows (in thousands, except amounts pertaining to rate which are shown as a percentage): 

 

   Year ended
September 30,
2025
 
Federal Statutory Rate   21.00%
Effect of:     
Change in Valuation Allowance   -23.20%
RTP & Deferred True-up   -0.03%
Change in Rate   0.22%
State Tax Benefit (Net of Fed)   2.09%
M&E   -0.10%
TX Franchise tax   0.00%
Others   0.00%
Total provision effective rate   -0.01%

 

The components of deferred tax assets and liabilities are as follows (in thousands): 

 

   September 30,
2025
 
Deferred tax assets relating to:    
Net Operating loss carryforwards  $4,254 
Research & development tax credit carryforward   7 
174 Expenses   889 
Right of Use Liability   169 
Other deferred tax assets   364 
Total gross deferred tax assets   5,683 
Deferred tax liabilities relating to:     
Right of Use Asset   169 
Fixed Asset   13 
Other deferred tax liabilities   
-
 
Total Gross deferred tax liabilities   182 
Deferred assets less liabilities   5,501 
Less: valuation allowance   (5,501)
Net deferred tax asset (liability)  $
-
 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based upon the level of historical taxable income (losses) and projections for future taxable income (losses) over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will not realize the benefits of these deductible differences in the future. The Company had the following federal net operating loss carryforward and research activities credits as of September 30, 2025 (in thousands): 

 

Year incurred  Net
Operating
Loss
   Research
Activities
Credit
 
2023   219    7.33 
2024   6,269    
-
 
2025   12,205      

Historical Timeline

Fiscal YearFiled
2025Jan 20, 2026Showing above
2024Jan 14, 2025
2023Jan 11, 2024

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.